New Delhi, Jun 16 (PTI) LIC has raised its stake in pharma major Dr Reddy's Laboratories to over 5 per cent by way of open market stock purchases during September 2021 to June this year, at an estimated cost of Rs 1,556 crore.

Corporation's shareholding in Dr Reddy's Laboratories has increased from 60,64,345 to 93,96,801 equity shares, or from 3.644 per cent to 5.646 per cent of the paid-up capital of the said company, LIC said in a regulatory filing on Thursday.

Also Read | Bitcoin Price Forecast: Will World's Number One Cryptocurrency Drop to $12,000?.

The life insurer said it bought shares through open market purchase from September 3, 2021 to June 15, 2022 at an average cost of Rs 4,670.46.

This translates into an investment of Rs 1,556.41 crore to buy over 33.3 lakh shares of the pharma company.

Also Read | Realme C30 India Launch on June 20, 2022; Teased on Flipkart.

Dr Reddy's is engaged in manufacturing of Active Pharamceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.

Shares of LIC closed 3.08 per cent lower at Rs 669.20 apiece on BSE. Dr Reddy's scrip ended 1.15 per cent down at Rs 4,287 apiece.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)